Mark W. Hahn

Filings by Mark W. Hahn span 2 companies, the busiest being Verona Pharma plc and Soleno Therapeutics Inc. Between 3 May 2021 and 13 October 2025, the trades on record add up to 43 filings.

Every open-market trade on record is a sale: 21 sales worth €17.1M. Outside the open market, there are 17 share grants and 3 option exercises. 2025 to date brings no purchases and 5 sales.

The record was last updated on 14 October 2025 with a share grant in Soleno Therapeutics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.